SCHEMBL7059574

SCHEMBL7059574

CCN(CC)Cc1cccc(NC(=O)Nc2csc(-c3ncccn3)n2)n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CDK5 Q00535 8/20 0.48
CDK5R1 Q15078 8/20 0.48
RAB9A P51151 2/20 0.37
SYK P43405 1/20 0.37
CHRNB2 P17787 1/20 0.36
CHRNB4 P30926 1/20 0.36
CHRNA3 P32297 1/20 0.36
CHRNA4 P43681 1/20 0.36
CCNA2 P20248 2/20 0.36
CDK2 P24941 2/20 0.36
CCNA1 P78396 2/20 0.36
PRKCA P17252 1/20 0.35
NPC1 O15118 1/20 0.35
GBA1 P04062 1/20 0.35
TP53 P04637 1/20 0.35
MAPT P10636 1/20 0.35
ROCK1 Q13464 1/20 0.35
MAPK8 P45983 1/20 0.35
CCR4 P51679 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5341200 0.87 CDK5 (0.60) CDK5CDK5R1RAB9ACCNA2CDK2
SCHEMBL5339186 0.86 CDK5 (0.53) CDK5CDK5R1RAB9ACCNA2CDK2
SCHEMBL5345614 0.85 CDK5 (0.47) CDK5CDK5R1RAB9ASYKCCNA2
SCHEMBL5354095 0.84 CDK5 (0.46) CDK5CDK5R1RAB9ASYKCCNA2
SCHEMBL5341715 0.83 CDK5 (0.47) CDK5CDK5R1RAB9ANPC1TP53
SCHEMBL5347914 0.83 CDK5 (0.46) CDK5CDK5R1RAB9ASYKCCNA2
SCHEMBL6629791 0.78 CDK5 (0.54) CDK5CDK5R1CCNA2CDK2CCNA1
SCHEMBL14558383 0.77 CDK5 (0.55) CDK5CDK5R1RAB9ASYKCHRNB2
SCHEMBL14558395 0.75 CDK5 (0.53) CDK5CDK5R1RAB9ACCNA2CDK2
SCHEMBL5689495 0.75 CDK5 (0.65) CDK5CDK5R1RAB9ASYKCHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1309589-A2 UREA COMPOUNDS AND METHODS OF USES Amgen Inc. (US) 2003-05-14 EP disclosed
WO-2002014311-A2 UREA COMPOUNDS AND METHODS OF USES AMGEN INC. (US) 2002-02-21 WO disclosed